Glioblastoma
Glioblastoma is a fast-growing and aggressive type of brain cancer that arises from glial cells, often leading to severe symptoms and a challenging prognosis.
Glioblastoma: Early Intensified Treatment with Temozolomide
We are studying whether starting chemotherapy earlier with temozolomide helps adults with glioblastoma live longer compared to standard treatment. The trial also examines safety and treatment effectiveness.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you 18 years old or older?
- Do you have a diagnosis of glioblastoma (GBM)?
- Are you currently pregnant or breastfeeding?
- Are you taking any medications that you are allergic to, such as dacarbazine (DTIC)?
- Have you had any other cancers in the last 5 years?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Hopital Erasme
neurosurgery department
Negenmanneke, Belgium
Centre Hospitalier Universitaire Amiens-Picardie
Neuro-oncology
Amiens, France
Centre Hospitalier Regional Et Universitaire De Brest
Oncology
Brest, France
Sponsor: Centre Oscar Lambret
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.